title: Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
authors.affiliation: Department of Surgery, Cedars'Sinai Medical Center, Los Angeles, California 90048, USA.
authors.forename: L S
authors.initials: LS
authors.lastname: Sher
authors.forename: C A
authors.initials: CA
authors.lastname: Cosenza
authors.forename: L M
authors.initials: LM
authors.lastname: Petrovic
authors.forename: S
authors.initials: S
authors.lastname: Rojter
authors.forename: A
authors.initials: A
authors.lastname: Hoffman
authors.forename: R R
authors.initials: RR
authors.lastname: Lopez
authors.forename: M
authors.initials: M
authors.lastname: Meehan
authors.forename: S H
authors.initials: SH
authors.lastname: Pan
authors.forename: J
authors.initials: J
authors.lastname: Vierling
authors.forename: L
authors.initials: L
authors.lastname: Makowka
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D001706:Biopsy; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus